诺诚健华11月13日举行董事会会议考虑及批准第三季度业绩

Core Viewpoint - The company, Innovent Biologics (09969.HK), has announced that it will hold a board meeting on November 13, 2025, to consider and approve its unaudited third-quarter results for the nine months ending September 30, 2025 [1] Group 1 - The board meeting is scheduled for November 13, 2025 [1] - The meeting will focus on the approval of the company's unaudited third-quarter performance [1] - The performance period under review is for the nine months ending September 30, 2025 [1]